These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2568272)

  • 1. [The pharmacology of 1-(2-pyrimidinyl)piperazine, a metabolite of buspirone].
    Komissarov IV; Dulenko VI; Kharin NA; Tolkunov SV; Talalaenko AN
    Farmakol Toksikol; 1989; 52(2):27-30. PubMed ID: 2568272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats.
    Amano M; Goto A; Sakai A; Achiha M; nee Hara ; Takahashi N; Hara C; Ogawa N
    Jpn J Pharmacol; 1993 Apr; 61(4):311-7. PubMed ID: 8100593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electroencephalographic study with buspirone, a novel nonbenzodiazepine anxiolytic, and its major metabolite, 1-(2-pyrimidinyl)piperazine (1-PP), in rabbits].
    Kawasaki H; Nakamura S; Takasaki K
    Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):91-104. PubMed ID: 1972369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of clonidine antinociception by buspirone and 1-(2-pyrimidinyl)-piperazine.
    Cao BJ; Li WP
    Eur J Pharmacol; 1994 Jun; 259(1):75-8. PubMed ID: 7957598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists].
    Talalaenko AN; Kharin NA
    Eksp Klin Farmakol; 1993; 56(2):11-3. PubMed ID: 8102289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The characteristics of the pharmacological action of buspirone].
    Dzhagatspanian IA; Asrian AB
    Eksp Klin Farmakol; 1994; 57(1):5-8. PubMed ID: 8142866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
    Cao BJ; Rodgers RJ
    Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone and 1-(2-pyrimidinyl)-piperazine attenuate xylazine-induced antinociception in the mouse.
    Cao BJ; Li WP
    J Pharm Pharmacol; 1994 Nov; 46(11):931-2. PubMed ID: 7897604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of buspirone and 1-(2-pyrimidinyl)-piperazine on cerebral glucose utilization in the rat.
    Grasby P; Sharp T; Moorman J; Grahame-Smith D
    Eur J Pharmacol; 1993 Jan; 230(1):41-6. PubMed ID: 8094054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
    Geller I; Hartmann RJ
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors.
    Khan A; Haleem DJ
    Acta Biol Hung; 2007 Dec; 58(4):345-57. PubMed ID: 18277461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models.
    Ogawa N; Hara C; Takaki S
    Jpn J Pharmacol; 1993 Feb; 61(2):115-21. PubMed ID: 8096257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives].
    Abramets II; Obraztsova OG; Samoĭlovich IM; Kharin NA
    Eksp Klin Farmakol; 1992; 55(3):8-11. PubMed ID: 1360856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of buspirone and buspirone-like 1-A-agonists of serotonin on the level of systemic blood pressure].
    Komissarov IV; Mamonov AV; Filippov IT
    Biull Eksp Biol Med; 1991 Jul; 112(7):62-4. PubMed ID: 1686564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The GABA-ergic component of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives].
    Abramets II; Talalaenko AN; Stakhovskiĭ IuV
    Eksp Klin Farmakol; 1992; 55(6):5-7. PubMed ID: 1363956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice.
    Sugimoto Y; Takashima N; Noma T; Yamada J
    J Pharmacol Sci; 2003 Dec; 93(4):446-50. PubMed ID: 14737015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine on hippocampal serotoninergic system, studied in freely moving rats.
    Grazia De Simoni M; Imeri L; De Luigi A; Fodritto F; Garattini S
    Life Sci; 1990; 46(3):197-205. PubMed ID: 1689445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the anxiolytic action of benzodiazepine and GABA derivatives on experimentally modelled anxiety states].
    Talalaenko AN; Zin'kovskaia LIa
    Farmakol Toksikol; 1988; 51(4):20-2. PubMed ID: 2903833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.